11-May-2026 - The Globe and Mail Viatris Earnings Call Highlights Profits, Pipeline Momentum Viatris’ latest earnings call struck a cautiously upbeat tone, as management emphasized steady revenue growth, expanding profitability and strong momentum in China alongside a deepening pipeline and ...
7-May-2026 - Yahoo Finance Assessing Viatris (VTRS) Valuation After Its Recent Share Price Rebound Why Viatris Stock Is Back On Investors’ Radar Viatris (VTRS) has quietly drawn fresh attention after a strong recent run, with the stock up about 32% over the past month and roughly 19% in the past 3 ...
7-May-2026 - StockStory.org Viatris’s (NASDAQ:VTRS) Q1 CY2026 beats on revenue Medication company Viatris (NASDAQ:VTRS) reported Q1 CY2026 results , with sales up 8.1% year on year to $3.52 billion. The ...
6-May-2026 - Investing Investors brace for Viatris earnings as CFO departure looms Wall Street expects Viatris to post earnings of $0.51 per share on revenue of $3.35 billion for the quarter ended March. That would represent a sequential decline from the fourth quarter, when the ...
6-May-2026 - Yahoo Finance Are Wall Street Analysts Bullish on Viatris Stock? Despite outperforming the broader market over the past year, Viatris continues to earn a cautiously optimistic outlook from ...
Latest VTRS Trades by Congress Members
18-NOV-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
11-May-2026 - The Globe and Mail Viatris Earnings Call Highlights Profits, Pipeline Momentum Viatris’ latest earnings call struck a cautiously upbeat tone, as management emphasized steady revenue growth, expanding profitability and strong momentum in China alongside a deepening pipeline and ...
7-May-2026 - Yahoo Finance Assessing Viatris (VTRS) Valuation After Its Recent Share Price Rebound Why Viatris Stock Is Back On Investors’ Radar Viatris (VTRS) has quietly drawn fresh attention after a strong recent run, with the stock up about 32% over the past month and roughly 19% in the past 3 ...
7-May-2026 - StockStory.org Viatris’s (NASDAQ:VTRS) Q1 CY2026 beats on revenue Medication company Viatris (NASDAQ:VTRS) reported Q1 CY2026 results , with sales up 8.1% year on year to $3.52 billion. The ...
6-May-2026 - Investing Investors brace for Viatris earnings as CFO departure looms Wall Street expects Viatris to post earnings of $0.51 per share on revenue of $3.35 billion for the quarter ended March. That would represent a sequential decline from the fourth quarter, when the ...
6-May-2026 - Yahoo Finance Are Wall Street Analysts Bullish on Viatris Stock? Despite outperforming the broader market over the past year, Viatris continues to earn a cautiously optimistic outlook from ...
